IP Library › Assignment 028757/0052
Patent Assignment
Reel/Frame 028757/0052

Change in Name and Country of Incorporation

Recorded: 2012-08-09 Received: 2012-08-09 Pages: 7
Assignor
Assignee
VALEANT INTERNATIONAL BERMUDA
C/O CODAN SERVICES LIMITED, CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON, BMX, HM11, BERMUDA
Covered Properties (43)
Method for Subcutaneous or Intradermal Injection
Application: 13/476,390 →
Controlled Release Dosage Forms
Application: 13/475,354 →
Controlled Release Dosage Forms
Application: 13/475,196 →
Controlled Release Dosage Forms
Application: 13/475,118 →
Pharmaceutical Compositions with Tetrabenazine
Application: 13/390,022 →
Ocular Strips
Application: 13/397,198 →
Cylindrical Ocular Inserts
Application: 13/397,185 →
Controlled Release Formulations Using Intelligent Polymers
Application: 13/341,134 →
Quick Dissolve Compositions and Tablets Based Thereon
Application: 13/314,592 →
Topical Skin Treatment Kits
Application: 13/213,471 →
Pharmaceutical Compositions
Application: 12/855,620 →
Bupropion Hydrobromide and Therapeutic Applications
Application: 12/740,223 →
Bupropion Hydrobromide and Therapeutic Applications
Application: 12/620,720 →
Bupropion Hydrobromide Polymorphs
Application: 12/536,772 →
Controlled Release Dosage Forms
Application: 12/328,828 →
Controlled Release Dosage Forms
Application: 12/169,852 →
Modified-Release Formulations of a Bupropion Salt
Application: 11/993,723 →
Bupropion Hydrobromide and Therapeutic Applications
Application: 11/930,644 →
Modified Release Formulations of at Least One Form of Tramadol
Application: 11/928,908 →
Bupropion Hydrobromide and Therapeutic Applications
Application: 11/834,848 →
Modified Release Formulations of a Bupropion Salt
Application: 11/774,109 →
Modified Release Formulations of a Bupropion Salt
Application: 11/766,213 →
Modified Release Formulations of a Bupropion Salt
Application: 11/766,251 →
Modified Release Formulations of a Bupropion Salt
Application: 11/766,239 →
Modified Release Formulations of a Bupropion Salt
Application: 11/762,820 →
Modified Release Formulations of a Bupropion Salt
Application: 11/762,840 →
Modified Release Formulations of a Bupropion Salt
Application: 11/762,343 →
Modified Release Formulations of a Bupropion Salt
Application: 11/759,413 →
Modified Release Formulations of a Bupropion Salt
Application: 11/755,946 →
Modified Release Formulations of a Bupropion Salt
Application: 11/751,768 →
Modified Release Formulations of a Bupropion Salt
Application: 11/751,785 →
Modified Release Formulations of a Bupropion Salt
Application: 11/475,252 →
Modified Release Tablet of Bupropion Hydrochloride
Application: 11/451,496 →
Piperidin-2,6-Dione Pamoate Salts and Their Use for the Treatment of Stress-Related Affective Disorders
Application: 10/524,693 →
Modified Release Compositions of at Least One Form of Tramadol
Application: 10/933,479 →
Implant for Subcutaneous or Intradermal Injection
Application: 10/809,349 →
Novel Piperidin-2,6-Dione Bisulphate Salts and Their Use for the Treatment of Stress Related Affective Disorders
Application: 10/486,925 →
Controlled Release Dosage Forms
Application: 10/370,109 →
Quick Dissolve Compositions and Tablets Based Thereon
Application: 10/176,135 →
Treating Eczema with a Combination of Isotonic Saline Ocean and Nasal Mast Cell Stabilizers
Application: 10/063,493 →
Sustained-Release Microgranules Containing Diltiazem as Active Principle
Application: 09/998,911 →
Extended Release Metformin Hydrochloride Formulations
Application: 09/845,496 →
Sustained-Release Microgranules Containing Diltiazem as Active Principle
Application: 09/757,628 →